https://www.selleckchem.com/pr....oducts/l-kynurenine.
After 12 months of follow-up, 41 (25.5%) cardiovascular complications were detected in the group of ACS patients with ADD and 20 (13.0%) in the group of ACS patients without ADD. According to the results of the analysis of the neural network based on NAD(P)-dependent dehydrogenases of platelets activity in ACS patients with ADD, indicators were obtained that are informative for predicting the development of recurrent cardiovascular complications.The present study describes the fabrication of molecularly imprinted (MI) magnetic bead
Like
Comment
Share
